Australian recommendations on perioperative use of disease-modifying anti-rheumatic drugs in people with inflammatory arthritis undergoing elective surgery
Files
(Published version)
Date
2023
Authors
Buchbinder, R.
Glennon, V.
Johnston, R.V.
Brennan, S.E.
Fong, C.
Edward May, S.
O'Neill, S.
Smitham, P.
Trevena, L.
Whittaker, G.
Editors
Advisors
Journal Title
Journal ISSN
Volume Title
Type:
Journal article
Citation
Internal Medicine Journal, 2023; 53(7):1248-1255
Statement of Responsibility
Rachelle Buchbinder, Vanessa Glennon, Renea V. Johnston, Sue E. Brennan, Chris Fong, Suzie Edward May, Sean O, Neill, Peter Smitham, Lyndal Trevena, Glen Whittaker, Anita Wluka, and Samuel L. Whittle
Conference Name
Abstract
Disease-modifying antirheumatic drugs (DMARDs) are effective treatments for inflammatory arthritis but carry an increased risk of infection. For patients undergoing surgery there is a need to consider the trade-off between a theoretical increased risk of infection with continuation of DMARDs perioperatively versus an increased risk of disease flare if they are temporarily withheld. We used GRADE methodology to develop recommendations for perioperative use of DMARDs for people with inflammatory arthritis undergoing elective surgery. The recommendations form part of the NHMRC-endorsed Australian Living Guideline for the Pharmacological Management of Inflammatory Arthritis. Conditional recommendations were made against routinely discontinuing conventional synthetic (cs) and biologic (b) DMARDs in the perioperative period but to consider temporary discontinuation of bDMARDs in individuals with a high risk of infection or where the impact of infection would be severe. A conditional recommendation was made in favour of temporary discontinuation of targeted synthetic (ts) DMARDs in the perioperative period.
School/Discipline
Dissertation Note
Provenance
Description
Published July 2023
Access Status
Rights
© 2023 The Authors. Internal Medicine Journal published by John Wiley & Sons Australia, Ltd on behalf of Royal Australasian College of Physicians. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.